Detalles de la búsqueda
1.
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Virol J
; 20(1): 154, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464440
2.
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
BMC Infect Dis
; 23(1): 118, 2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36829111
3.
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.
Vaccines (Basel)
; 10(11)2022 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366308
4.
Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models.
Vaccines (Basel)
; 9(11)2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34835202
5.
Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli.
Iran J Immunol
; 16(3): 200-211, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31552829
6.
Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC.
Immunobiology
; 224(2): 262-269, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579628
Resultados
1 -
6
de 6
1
Próxima >
>>